Please wait while the formulary information is being retrieved.
OMIDRIA (PHENYLEPHRINE HCL/KETOROLAC TROMETHAMINE)
- Mydriasis during ocular surgery
- Postoperative ocular pain
1 %-0.3 % intraocular concentrate
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Angle-closure glaucoma
Contraindicated
- None
Severe
Moderate
- Atherosclerotic cardiovascular disease
- Benign prostatic hyperplasia
- Cardiac arrhythmia
- Cardiac disease
- Corneal degeneration
- Corneal erosion
- Coronary artery disease
- Diabetes mellitus
- Dry eye
- Hemophilia
- Hypertension
- Hyperthyroidism
- Increased risk of bleeding due to coagulation disorder
- Rheumatoid arthritis
OMIDRIA (PHENYLEPHRINE HCL/KETOROLAC TROMETHAMINE)
- Mydriasis during ocular surgery
- Postoperative ocular pain
- None
- Anterior chamber inflammation
- Posterior capsule opacification
More Frequent
Severe
Less Severe
- Ocular hypertension
- Foreign body sensation of eye
- Ocular irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bronchospastic pulmonary disease
- Hypersensitivity drug reaction
- Hypertension
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Ketorolac (ophth)
- Severity Level:
2
- Additional Notes: Insufficient human data avail; animal data do not sug dev tox
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ketorolac (ophth)
Systemic absorption likely minimal;Oral product excreted
Some syst absorpt w/ophth use;Poor oral bioavail,unlikely clin signif effect
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Systemic absorption likely minimal;Oral product excreted |
Phenylephrine (ophth)
Systemic absorption likely minimal;Oral product excreted
Some syst absorpt w/ophth use;Poor oral bioavail,unlikely clin signif effect
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Some syst absorpt w/ophth use;Poor oral bioavail,unlikely clin signif effect |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Postoperative ocular pain | |
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
| 0-9 | A-Z |
|---|---|
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
Formulary Reference Tool